Nuvaxovid Vaccine
The National Advisory Committee on Immunization continues to strongly recommend the use of mRNA COVID-19 vaccines due to the excellent protection they provide against severe illness and hospitalization. Novavax vaccine is a recombinant protein subunit COVID-19 vaccine that is available to those 18 years and older who are not able or willing to receive an mRNA COVID-19 vaccine. A primary series of Novavax is 2 doses.
Novavax may be offered as a booster dose to people who are not willing or not able to receive an mRNA vaccine, regardless of which COVID-19 vaccines they may have already received. Health Canada authorized the use of Novavax as a booster dose in people 18 years and older on November 17, 2022.
Eligibility
- 18 years or older
- No allergy to any of the vaccine ingredients
- Not able or not willing to receive an mRNA COVID-19 vaccine
- For those getting their first or second dose of any COVID-19 vaccine:
- A recommended two months (56 days) have passed since your last COVID-19 vaccine. You must wait a minimum of one month (28 days).
- If you recently had COVID-19, we recommend that you wait two months (56 days) after you first got symptoms or after a positive test. For those who are immunocompromised or have a history MIS-C, please see Ontario guidance.
- For those getting their booster dose: 6 months (168 days) have passed since getting COVID-19 or since your last COVID-19 vaccine. The minimum interval is 3 months (84 days).
- If appointments fill up, KFL&A area residents will be prioritized. You may get a call cancelling your appointment if you are a resident outside of the KFL&A area.
Resources
- COVID-19 Vaccine Information Sheet (ages 12 and older) (PDF) - Ontario Ministry of Health and Long Term Care
- Summary of National Advisory Committee on Immunization (NACI) Statement (PDF) - Public Health Agency of Canada
- Novavax Nuvaxovid COVID-19 vaccine - Government of Canada